Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$MediciNova (MNOV.US)$ MediciNova Receives a Notice of Allow...

$MediciNova(MNOV.US)$ MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
Translate
Report
2313 Views
Comment
Sign in to post a comment
Here to scalp my daily meals
60Followers
16Following
336Visitors
Follow